1. "Weinberg Fellows"
Formats
  1. Meeting Abstract (1211)
  2. Journal Article (1028)
  3. Review (105)
  4. Editorial (51)
  5. Research Letter (27)
  6. Book Section (22)
  7. Correspondence (20)
  8. Guidelines (11)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Weinberg Fellows (2478)
  2. Department of Medicine (2385)
  3. Solid Tumor Oncology Division (1832)
  4. Hematologic Malignancies, Division of (1138)
  5. GSK Faculty (1085)
  6. Department of Pathology and Laboratory Medicine (896)

More Groups

People
  1. Michael Berger (214)
  2. Marc Ladanyi (188)
  3. Pedram Razavi (172)
  4. Michael Offin (170)
  5. David Solit (165)
  6. Maria Carlo (162)

More People

Years
  1. 2025 (91)
  2. 2024 (342)
  3. 2023 (292)
  4. 2022 (347)
  5. 2021 (307)
  6. 2020 (307)

More Years

Publications
  1. Journal of Clinical Oncology (529)
  2. Blood (219)
  3. Annals of Oncology (98)
  4. Clinical Cancer Research (92)
  5. Cancer Research (80)
  6. Journal of Thoracic Oncology (80)

More Publications

Publishers
  1. American Society of Clinical Oncology (595)
  2. Elsevier Inc. (352)
  3. American Society of Hematology (252)
  4. American Association for Cancer Research (214)
  5. Nature Publishing Group (171)
  6. Oxford University Press (147)

More Publishers

Results (2478)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association between clonal hematopoiesis and survival after nephrectomy in patients with renal cell carcinoma
    Meeting Abstract

    Khandwala, Y.; Ruthen, N.; Kotecha, R. R.; Russo, P.; Coleman, J.; Reznik, E.; Hakimi, A. A.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Punekar, S. R.; Hong, D. S.; Luo, J.; Ou, S. H. I.; Johnson, M. L.; Spira, A.; Garrido-Laguna, I.; Goldman, J. W.; Herzberg, B.; Saltos, A.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Enhancing enrollment to 1L NSCLC trials by allowing 1 prior cycle of standard of care (SOC): SUNRAY-01 experience
    Meeting Abstract

    Hochmair, M. J.; Arbour, K. C.; Negrao, M. V.; Cappuzzo, F.; Dingemans, A. M. C.; Girard, N.; Gronberg, B. H.; Leal, T. A.; Lindsay, C.; Lu, S.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Can longitudinal biomarkers guide treatment decisions? Time will tell
    Editorial

    Jeng, M. Y.; Schoenfeld, A. J.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Artificial intelligence to enhance precision medicine in cardio-oncology: A scientific statement from the American Heart Association
    Guidelines

    Khera, R.; Asnani, A. H.; Krive, J.; Addison, D.; Zhu, H.; Vasbinder, A.; Fleming, M. R.; Arnaout, R.; Razavi, P.; Okwuosa, T. M.; more...
    Circulation-Genomic and Precision Medicine (2025)

    Fulltext@MSK | Save
  • RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
    Journal Article

    Sethna, Z.; Guasp, P.; Reiche, C.; Milighetti, M.; Ceglia, N.; Patterson, E.; Lihm, J.; Payne, G.; Lyudovyk, O.; Rojas, L. A.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity
    Journal Article

    Baatz, F.; Ghosh, A.; Herbst, J.; Polten, S.; Meyer, J.; Rhiel, M.; Maetzig, T.; Geffers, R.; Rothe, M.; Bastone, A. L.; more...
    Molecular Therapy (2025)

    Fulltext@MSK | Save
  • α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia
    Journal Article

    Millman, S. E.; Chaves-Perez, A.; Janaki-Raman, S.; Ho, Y. J.; Morris, J. P. 4th; Narendra, V.; Chen, C. C.; Jackson, B. T.; Yashinskie, J. J.; Mezzadra, R.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
    Journal Article

    Galera, P.; Dilip, D.; Derkach, A.; Chan, A.; Zhang, Y.; Persaud, S.; Mishra, T.; Kramer, K.; Kathpalia, M.; Liu, Y.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Venetoclax–azacitidine versus azacitidine for the treatment of primary refractory or first relapsed acute myeloid leukemia. An IPC-DATAML-MSKCC retrospective study
    Correspondence

    Petit, C.; Higue, J.; Acheaibi, Z.; Gilhodes, J.; Hospital, M. A.; Devillier, R.; Bewersdorf, J.; Goldberg, A. D.; Pigneux, A.; Vey, N.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save